Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 0.12% Nasdaq Down 0.07%
Streaming
Ticker Tape: On

More On DIVISLAB.BO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Divi's Laboratories Limited (DIVISLAB.BO)

-BSE

1,086.70 Down 34.45(3.07%) 6:12AM EDT

Add to Portfolio
Prev Close:1,121.15
Open:1,124.05
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1,078.05 - 1,130.60
52wk Range:898.30 - 1,233.00
Volume:15,814
Avg Vol (3m):7,151
Market Cap:144.24B
P/E (ttm):27.04
EPS (ttm):40.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Headlines

  • No Headlines available for DIVISLAB.BO at this time.

Reports

  • No Reports available for DIVISLAB.BO at this time.

Comparison

Symbol% ChgMkt Cap
DIVISLAB.BODown 3.07%144.24B
DRREDDY.NSDown 1.61%347.29B
DRREDDY.BODown 1.45%347.76B
HIK.LDown 0.41%1.92B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Divi’s Laboratories Limited engages in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for generics in India. It provides building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarot... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback